SPARC receives SEBI approval to raise up to Rs 250 crore via rights issue
Sun Pharma Advanced Research Company (SPARC) has got the market regulator SEBI’s consent for raising funds up to Rs 250 crore through a right issue....
Download Unicorn Signals App
Powered By EquityPandit
